Furthermore, the Annexin V–FITC/PI assay, implemented to evaluate the effect of EPI on 125I-induced apoptosis of HCC cells, showed a significantly higher rate of apoptosis in the combined test group than in either the EPI or 125I individual treatment groups (Figures 2D–F). This evidence concerns the gene ANXA5 and hepatocellular carcinoma.